Surprisingly, although ERG1C1 expression was associated with AR and AR driven ERG expression in clinical prostate cancers, no major changes were observed in the expression of ERGIC1 mRNA expression in response to AR silencing. This evidence concerns the gene ERGIC1 and prostate cancer.